Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shiro Ikegami

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
The Journal of Biological Chemistry|November 13, 2019
mTORC2 links growth factor signaling with epigenetic regulation of iron metabolism in glioblastomaKenta Masui, Mio Harachi, Shiro Ikegami, et al.
Learning & Memory (Cold Spring Harbor, N.Y.)|March 25, 2010
Activin plays a key role in the maintenance of long-term memory and late-LTPHiroshi Ageta, Shiro Ikegami, Masami Miura, et al.
Plos One|September 28, 2011
A single amino acid mutation in SNAP-25 induces anxiety-related behavior in mouseMasakazu Kataoka, Saori Yamamori, Eiji Suzuki, et al.
Molecular Cell|June 27, 2017
mTORC2 Regulates Amino Acid Metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCTYuchao Gu, Claudio P Albuquerque, Daniel Braas, et al.
Cancer Cell|April 13, 2016
Single-Cell Phosphoproteomics Resolves Adaptive Signaling Dynamics and Informs Targeted Combination Therapy in GlioblastomaWei Wei, Young Shik Shin, Min Xue, et al.
Cell Metabolism|July 16, 2019
Oncogene Amplification in Growth Factor Signaling Pathways Renders Cancers Dependent on Membrane Lipid RemodelingJunfeng Bi, Taka-Aki Ichu, Ciro Zanca, et al.
Molecular Cell|October 13, 2015
EGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network RemodelingFeng Liu, Gary C Hon, Genaro R Villa, et al.
Cancer Cell|October 18, 2016
An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain CancersGenaro R Villa, Jonathan J Hulce, Ciro Zanca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2013
The mTOR kinase inhibitors, CC214-1 and CC214-2, preferentially block the growth of EGFRvIII-activated glioblastomasBeatrice Gini, Ciro Zanca, Deliang Guo, et al.
Genes & Development|July 21, 2017
Glioblastoma cellular cross-talk converges on NF-κB to attenuate EGFR inhibitor sensitivityCiro Zanca, Genaro R Villa, Jorge A Benitez, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
The Journal of Biological Chemistry|November 13, 2019
mTORC2 links growth factor signaling with epigenetic regulation of iron metabolism in glioblastomaKenta Masui, Mio Harachi, Shiro Ikegami, et al.
Learning & Memory (Cold Spring Harbor, N.Y.)|March 25, 2010
Activin plays a key role in the maintenance of long-term memory and late-LTPHiroshi Ageta, Shiro Ikegami, Masami Miura, et al.
Plos One|September 28, 2011
A single amino acid mutation in SNAP-25 induces anxiety-related behavior in mouseMasakazu Kataoka, Saori Yamamori, Eiji Suzuki, et al.
Molecular Cell|June 27, 2017
mTORC2 Regulates Amino Acid Metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCTYuchao Gu, Claudio P Albuquerque, Daniel Braas, et al.
Cancer Cell|April 13, 2016
Single-Cell Phosphoproteomics Resolves Adaptive Signaling Dynamics and Informs Targeted Combination Therapy in GlioblastomaWei Wei, Young Shik Shin, Min Xue, et al.
Cell Metabolism|July 16, 2019
Oncogene Amplification in Growth Factor Signaling Pathways Renders Cancers Dependent on Membrane Lipid RemodelingJunfeng Bi, Taka-Aki Ichu, Ciro Zanca, et al.
Molecular Cell|October 13, 2015
EGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network RemodelingFeng Liu, Gary C Hon, Genaro R Villa, et al.
Cancer Cell|October 18, 2016
An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain CancersGenaro R Villa, Jonathan J Hulce, Ciro Zanca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2013
The mTOR kinase inhibitors, CC214-1 and CC214-2, preferentially block the growth of EGFRvIII-activated glioblastomasBeatrice Gini, Ciro Zanca, Deliang Guo, et al.
Genes & Development|July 21, 2017
Glioblastoma cellular cross-talk converges on NF-κB to attenuate EGFR inhibitor sensitivityCiro Zanca, Genaro R Villa, Jorge A Benitez, et al.
Pageof 4